severe myopathy in patients taking both a statin and gemfibrozil (Lopid)

How can you reduce the risk of severe myopathy in patients taking both a statin and gemfibrozil (Lopid)?

This combo is being used more these days...for patients who need to lower both LDL cholesterol and triglycerides.

The problem is that each drug can cause myopathy. The risk is low...but it's higher when the drugs are combined.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote